ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,027,000 | -28.9% | 450,000 | 0.0% | 1.25% | -20.5% |
| Q2 2023 | $12,694,500 | +23.0% | 450,000 | -25.0% | 1.57% | -24.4% |
| Q1 2023 | $10,320,000 | -31.7% | 600,000 | -20.0% | 2.08% | -34.4% |
| Q4 2022 | $15,105,000 | +26.8% | 750,000 | +36.4% | 3.17% | +37.0% |
| Q3 2022 | $11,913,000 | +24.6% | 550,000 | +61.6% | 2.31% | +17.6% |
| Q2 2022 | $9,561,000 | -3.6% | 340,243 | +58.3% | 1.97% | -23.8% |
| Q1 2022 | $9,920,000 | -1.7% | 215,000 | +79.2% | 2.58% | -7.5% |
| Q4 2021 | $10,087,000 | +68.2% | 120,000 | +33.3% | 2.79% | +61.9% |
| Q3 2021 | $5,998,000 | -9.8% | 90,000 | -28.0% | 1.72% | -5.8% |
| Q2 2021 | $6,650,000 | +283.1% | 125,000 | +212.5% | 1.83% | +269.2% |
| Q1 2021 | $1,736,000 | – | 40,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |